
Tarek Haykal MD MHS
Hematology/Oncology
Assistant professor at the University of Michigan
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Haykal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Lebanese University School of MedicineClass of 2016
Certifications & Licensure
- MI State Medical License 2017 - 2027
- OH State Medical License 2023 - 2025
- NC State Medical License 2020 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03 - 3 citationsGuide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice.Nazli Dizman, Ziad Bakouny, Tarek Haykal, Ivy Riano, Aakash Desai
JCO Oncology Practice. 2025-03-01 - Neoadjuvant treatment in advanced resectable melanoma and the need for a predictive biomarker - is pathologic complete response (pCR) the answer?Nathaniel R Wilson, Christina V Angeles, Tarek Haykal
American Journal of Surgery. 2025-01-21
Journal Articles
- Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled TrialsDeepak L Bhatt, Tarek Haykal, Meghan Gwinn, Babikir Kheiri, Ghassan Bachuwa, ScienceDirect
Lectures
- Safety and efficacy of aspirin for primary prevention of cancer: A meta-analysis of randomized controlled trials.2019 ASCO Annual Meeting - 6/1/2019
- Efficacy and safety profile of sunitinib as a first line treatment for advanced/metastatic clear-cell renal cell carcinoma: Pooled analysis of randomized controlled tr...2019 ASCO Annual Meeting - 6/1/2019
- Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Soak up the Sun! 19 Awesome Health Benefits from Vitamin D, According to StudiesJanuary 21st, 2023
- Thromboprophylaxis with Anticoagulants “Likely Effective” at Preventing VTE Post-Vascular Surgery, Larger Trials NeededSeptember 9th, 2021
- The Vitamin That Cuts Cancer Risk 13 PercentJuly 11th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: